Table 4.
Univariate and Multivariate Cox Hazard Ratio Analysis Identifying Characteristics Associated with Death.
Variable | Univariate Analysis: Hazard Ratio (95% CI) | Multivariate Analysis: Adjusted Hazard Ratio (95% CI) |
---|---|---|
Age Category | ||
Age < 60 years | Reference | Reference |
Age ≥ 60 years | 4.78 (4.64–4.92) | 3.79 (3.68–3.89) |
Sex | ||
Female | Reference | Reference |
Male | 1.74 (1.70–1.78) | 1.32 (1.27–1.38) |
Anatomic Region | ||
Trunk | Reference | Reference |
Head and Neck | 1.90 (1.85–1.96) | 1.30 (1.27–1.37) |
Upper Extremity/Shoulder | 1.06 (1.03–1.10) | 0.97 (0.92–1.03) |
Lower Extremity/Hip | 0.86 (0.82–0.89) | 0.88 (0.82–0.94) |
AJCC Overall Stage | ||
I | Reference | Reference |
II | 3.88 (3.77–4.00) | 1.27 (1.15–1.39) |
III | 4.82 (4.65–4.99) | 2.67 (2.42–2.95) |
IV | 22.45 (21.42–23.53) | 6.00 (5.34–6.76) |
Surgical Management | ||
None | Reference | Reference |
Local Tumor Excision | 0.54 (0.51–0.57) | 0.60 (0.53–0.68) |
Gross Excision < 1 mm | 0.32 (0.30–0.33) | 0.38 (0.34–0.42) |
Gross Excision > 1 mm | 0.41 (0.40–0.43) | 0.40 (0.36–0.45) |
Surgery NOS | 0.95 (0.82–1.10) | 0.51 (0.29–0.91) |
SLNB | ||
None | Reference | Reference |
Yes | 1.03 (1.00–1.06) | 0.55 (0.52–0.58) |
Mitoses | ||
None | Reference | Reference |
Yes | 3.09 (2.91–3.27) | 1.29 (1.20–1.40) |
Ulceration | ||
None | Reference | Reference |
Yes | 4.14 (4.03–4.24) | 1.81 (1.71–1.91) |
Breslow’s Depth | ||
0.0–1.00 mm | Reference | Reference |
1.01 0 2.00 mm | 1.95 (1.88–2.02) | 1.81 (1.63–1.94) |
2.01–4.00 mm | 3.93 (3.81–4.07) | 2.33 (2.11–2.57) |
>4.0 mm | 7.36 (7.13–7.61) | 3.19 (2.89–3.52) |
Histological Type | ||
Superficial Spreading Melanoma | Reference | Reference |
Lentigo Maligna Melanoma | 2.25 (2.14–2.36) | 1.26 (1.15–1.37) |
Nodular Melanoma | 4.15 (4.01–4.30) | 1.20 (1.13–1.29) |
Malignant Melanoma NOS | 1.52 (1.39–1.66) | 1.06 (1.01–1.12) |
Desmoplastic Melanoma, Malignant | 1.14 (0.29–4.57) | 0.96 (0.84–1.11) |
Spindle Cell Melanoma | 1.76 (1.61–1.91) | 0.94 (0.83–1.08) |
Abbreviations: SLNB, Sentinel Lymph Node Biopsy.